|
|
Article: 'Adipose-derived' Stem Cells Could Help Traumatic Brain Injury Patients, Says Bio-Matrix Scientific Group's, Entest BioMedical Inc. Researcher.
- Article from:
- Obesity & Diabetes Week
- Article date:
- May 25, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Dr. Feng Lin, Director of Research at Bio-Matrix Scientific Group Inc. (BULLETIN BOARD: BMSN) and Entest BioMedical Inc., today stated that he believes that an effective new therapy for "traumatic brain injury" (TBI) using autologous "adipose-derived" stem cells represents a potential cure for TBI. According to Dr. Lin, both Bio-Matrix and Entest BioMedical are now studying the "therapeutic effect of fat stem cells on traumatic brain injury-associated brain ischemia and inflammation and replacement of damaged neurons with neuron cells differentiated from fat cells." Bio-Matrix Scientific Group Inc. and Entest BioMedical Inc. recently submitted a research summary proposal ...
Related newspaper, magazine, and journal articles:
|
|
Article: Bio-Matrix Scientific Group's Subsidiary ...
Business Wire;
October 7, 2009 ;
700+ words
... ... owned subsidiary of Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN ... Chairman and CEO of Bio-Matrix Scientific Group and its majority owned subsidiary ... with cancer. About Bio-Matrix Scientific Group Bio-Matrix Scientific ...
|
|